These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3816364)

  • 1. [Comparison of plaque reduction and active mouse protection tests for estimating the potency of Japanese encephalitis vaccine].
    Chou FY; Chang SN; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Aug; 19(3):197-202. PubMed ID: 3816364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
    Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
    Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the potency of BIKEN inactivated Japanese Encephalitis vaccine and DNA vaccines in an intracerebral Japanese Encephalitis virus challenge.
    Ashok MS; Rangarajan PN
    Vaccine; 2000 Sep; 19(2-3):155-7. PubMed ID: 11032563
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2.
    Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
    Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pregnancy on protection of mice immunized by Japanese encephalitis virus & its experimental inactivated vaccine.
    Soni GR
    Indian J Med Res; 1994 Aug; 100():57-8. PubMed ID: 7927555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
    Gowal D; Tahlan AK
    Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on immune response of attenuated Japanese encephalitis vaccine virus strain].
    Chen BQ; Tignor CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):378-81. PubMed ID: 6233022
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu.
    Mohan Rao CV; Risbud AR; Dandawate CN; Umarani UB; Ayachit VM; Rodrigues FM; Pavri KM
    Indian J Med Res; 1993 Mar; 97():53-9. PubMed ID: 8505074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of immunodominant fragments from envelope gene for vaccine against Japanese encephalitis virus in DNA priming-protein boosting protocols.
    Chen CT; Yi YC; Chiang SC; Liu KC; Lin YL; Lee ST
    Microb Pathog; 2005; 38(2-3):53-62. PubMed ID: 15748807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of protection by Japanese encephalitis (JE) vaccine against a Japanese strain and an Indian strain of JE virus.
    Das BC; Chakrabarti SK; Sarkar JK; Mukherjee KK
    Indian J Pathol Microbiol; 1976 Oct; 19(4):239-43. PubMed ID: 191395
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Certain characteristics of Japanese encephalitis virus strains by neutralization test.
    Banerjee K
    Indian J Med Res; 1986 Mar; 83():243-50. PubMed ID: 3733180
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.